Translation
Help Questions
AP Biology › Translation
During translation, a ribosome begins at a start codon and reads an mRNA 5′→3′ in sets of three nucleotides. A student compares two mRNAs that are identical except at codon 4: mRNA 1 has 5′-AUG GCU UAC GAA CCG-3′, and mRNA 2 has 5′-AUG GCU UAC UAA CCG-3′. In this system, UAA is a stop codon recognized by a release factor rather than a tRNA. All other codons shown are sense codons that recruit tRNAs carrying amino acids. Which outcome is most likely for translation of mRNA 2 compared with mRNA 1?
The polypeptide will be longer because the ribosome skips the stop codon and continues elongation.
No polypeptide will form because RNA polymerase cannot transcribe an mRNA containing UAA.
The polypeptide will be shorter because termination occurs at codon 4 after release factor binding.
A different amino acid will be inserted at codon 4 because UAA pairs with a complementary tRNA anticodon.
The same-length polypeptide will form because codon 4 changes only the DNA template strand.
Explanation
This question tests your ability to analyze how stop codons affect translation outcomes. In mRNA 2, codon 4 changes from GAA (which codes for glutamate) to UAA, which is a stop codon that recruits release factors instead of tRNAs. When the ribosome encounters UAA at codon 4, the release factor binds and triggers termination, producing a polypeptide containing only the amino acids from codons 1-3 (Met-Ala-Tyr). Students choosing B incorrectly think ribosomes can skip stop codons, but release factors specifically recognize stop codons and cause termination. To solve translation problems, identify stop codons (UAA, UAG, UGA) and remember they always trigger termination when encountered.
During translation, a ribosome begins at the start codon and reads mRNA in groups of three nucleotides (codons). A student provides an mRNA segment: 5′-AUG GCU UAC GAA UGA-3′. The tRNA carrying methionine binds the start codon, and each subsequent codon is matched by a tRNA with a complementary anticodon, adding one amino acid per codon. Translation ends when a stop codon enters the ribosome, and no tRNA binds that codon. Assume this segment is in-frame and is translated without skipping or editing. Which outcome is most likely for the polypeptide produced from this mRNA segment?
A polypeptide of four amino acids is produced because the ribosome reads codons as overlapping pairs.
A polypeptide of three amino acids is produced because translation starts at GCU, not AUG.
A polypeptide of four amino acids is released when the ribosome reaches UGA.
A polypeptide of five amino acids is released because UGA codes for the final amino acid.
No polypeptide is produced because AUG is transcribed only in the nucleus, not translated.
Explanation
This question assesses the skill of analyzing translation by interpreting an mRNA sequence to determine the resulting polypeptide. The ribosome initiates at the start codon AUG, which codes for methionine, and then reads subsequent codons GCU (alanine), UAC (tyrosine), and GAA (glutamic acid), adding each corresponding amino acid to the growing chain. Translation proceeds until the stop codon UGA enters the ribosome, at which point no tRNA binds, and the polypeptide is released without adding an amino acid for the stop codon. Thus, the mRNA segment produces a polypeptide with four amino acids: methionine-alanine-tyrosine-glutamic acid. A tempting distractor is B, which claims a five-amino-acid polypeptide because UGA codes for a final amino acid, but this is incorrect due to the misconception that stop codons encode amino acids rather than signaling termination. To solve similar problems, always count the number of codons from the start codon up to but not including the stop codon, as stop codons do not add amino acids.
A student analyzes two mRNAs translated in the same cytosol. Both contain the same start codon and the same stop codon positions, but one has a single-base substitution that changes one codon to a different codon. The student is told that the new codon is recognized by a different tRNA carrying a different amino acid, and no other codons change. The ribosome reads codons sequentially and adds amino acids to the C-terminus of the growing chain. Which outcome is most likely for the mutant polypeptide compared with the original?
No polypeptide forms because a single codon change prevents ribosome binding at the start codon.
The polypeptide becomes shorter because substitutions are removed by the ribosome during elongation.
The polypeptide becomes longer because a substitution inserts an extra codon into the mRNA.
One amino acid substitution occurs at the position specified by the mutated codon.
All downstream amino acids change because any substitution causes a shift in the reading frame.
Explanation
This question assesses the skill of analyzing translation by examining the impact of a missense mutation on the polypeptide sequence. The single-base substitution changes one codon to another that codes for a different amino acid, but it does not alter the reading frame or the positions of the start and stop codons. The ribosome translates the mRNAs sequentially, incorporating the altered amino acid only at the position of the mutated codon, while all other amino acids remain the same. Thus, the mutant polypeptide differs by a single amino acid substitution at that specific position compared to the original. A tempting distractor is B, which states all downstream amino acids change due to a reading frame shift, but this is incorrect due to the misconception that nucleotide substitutions cause frameshifts like insertions or deletions do. When analyzing point mutations, use a codon table to check if the change affects only one codon and amino acid, without shifting the frame for subsequent codons.
During translation, the ribosome moves along mRNA in the 5′ to 3′ direction, decoding each codon in order. A researcher introduces an mRNA in which the start codon AUG is unchanged, but the stop codon is mutated to a sense codon that is recognized by a tRNA. The mRNA sequence downstream contains additional codons before a later stop codon. Assume initiation occurs normally and the ribosome remains bound to the mRNA. Which outcome is most likely for the translated product compared with the original mRNA?
A shorter polypeptide is produced because mutating a stop codon prevents initiation at AUG.
No polypeptide is produced because a sense codon cannot be read by the ribosome.
An identical polypeptide is produced because stop codons do not affect translation length.
A longer polypeptide is produced because translation continues to the next in-frame stop codon.
A longer mRNA is produced because translation adds nucleotides after the mutated stop codon.
Explanation
This question assesses the skill of analyzing translation by predicting the effect of mutating a stop codon to a sense codon on polypeptide length. Mutating the stop codon to a sense codon allows a tRNA to bind and add an amino acid at that position, preventing normal termination. The ribosome continues translating downstream codons until it reaches the next in-frame stop codon further along the mRNA. As a result, the translated product is a longer polypeptide incorporating additional amino acids beyond the original termination site. A tempting distractor is B, which claims a shorter polypeptide because the mutation prevents initiation at AUG, but this is incorrect due to the misconception that downstream mutations affect upstream initiation rather than only elongation and termination. To evaluate similar mutations, trace the translation path from the unchanged start codon and note how changes in stop signals extend or shorten the coding sequence.
Translation requires that the ribosome maintain a reading frame, grouping nucleotides into codons from the start codon. A wild-type mRNA segment is 5′-AUG AAA CCG UUU GGA UAA-3′. In a mutant, a single nucleotide is inserted immediately after the start codon, producing 5′-AUG UAAA ACC GUU UGG AUAA-3′ when regrouped from the same start site. Assume the ribosome initiates at AUG in both cases and continues until it encounters the first in-frame stop codon. Which outcome is most likely for the mutant compared with the wild type?
The mutant polypeptide is identical because ribosomes remove inserted nucleotides during translation.
No mutant polypeptide forms because insertions prevent transcription of the mRNA in the nucleus.
The mutant polypeptide is longer because insertions always eliminate stop codons from mRNA.
The mutant polypeptide is unchanged because tRNA anticodons determine the mRNA sequence.
The mutant polypeptide differs because the insertion shifts the reading frame for downstream codons.
Explanation
This question assesses the skill of analyzing translation by evaluating the impact of a frameshift mutation on the reading frame and polypeptide sequence. The insertion of a single nucleotide after the start codon shifts the grouping of all downstream nucleotides into codons, changing the sequence from the wild-type AUG-AAA-CCG-UUU-GGA-UAA to the mutant AUG-UAA-AAC-CGU-UUG-GAU-AA in the provided regrouping. This frameshift alters the amino acids specified by the new codons and may change when the ribosome encounters an in-frame stop codon, resulting in a different polypeptide. Consequently, the mutant polypeptide differs from the wild-type due to the shifted reading frame affecting all codons after the insertion point. A tempting distractor is A, which states the polypeptide is identical because ribosomes remove inserted nucleotides, but this is incorrect due to the misconception that ribosomes edit mRNA during translation rather than reading it as is. To approach similar mutation problems, redraw the codon groupings starting from the start codon to visualize how insertions or deletions shift the frame and alter the sequence.
A scientist tests a drug that prevents the large ribosomal subunit from catalyzing peptide bond formation but does not prevent tRNA anticodons from pairing with mRNA codons. In treated cells, initiation still occurs at the start codon, and tRNAs can enter the ribosome according to codon-anticodon complementarity. However, the growing polypeptide cannot be transferred to the incoming aminoacyl-tRNA. Assume mRNA levels and transcription are unchanged. Which outcome is most likely in treated cells compared with untreated cells?
More mRNA is produced because blocking translation increases RNA polymerase activity.
Longer polypeptides accumulate because tRNAs remain bound and add amino acids without peptide bonds.
Normal-length polypeptides form because codon-anticodon pairing alone creates covalent links.
Short peptide fragments fail to elongate because peptide bond formation is required for chain growth.
Translation proceeds normally because the small subunit catalyzes peptide bonds during elongation.
Explanation
This question assesses the skill of analyzing translation by predicting the consequences of inhibiting peptide bond formation during elongation. The drug blocks the large ribosomal subunit's peptidyl transferase activity, preventing the transfer of the growing polypeptide to the incoming aminoacyl-tRNA despite codon-anticodon pairing. Although initiation and tRNA binding can occur, the chain cannot grow beyond the initial amino acid, leading to stalled ribosomes and short peptide fragments. In treated cells, full-length polypeptides cannot form, resulting in a failure to produce functional proteins compared to untreated cells. A tempting distractor is D, which claims normal-length polypeptides form because codon-anticodon pairing creates covalent links, but this is wrong due to the misconception that base pairing alone forms peptide bonds without ribosomal catalysis. To evaluate similar inhibitor effects, identify which step of translation is blocked and trace how it halts the process, preventing downstream outcomes like chain elongation.
Two mRNAs differ at a single codon within an otherwise identical coding sequence. At position 5, mRNA X contains a codon that is recognized by a specific tRNA carrying amino acid M, while mRNA Y contains a different codon recognized by a different tRNA carrying amino acid N. Neither codon is a stop codon, and initiation occurs at the same start codon for both mRNAs. All translation components are present. Which outcome is most likely when comparing the polypeptides produced?
The polypeptides will differ by one amino acid at position 5 because different tRNAs deliver different amino acids.
Both polypeptides will be shorter because any codon change causes release factor binding and termination.
The polypeptides will differ in length because the altered codon changes the number of nucleotides in the mRNA.
mRNA Y will not be translated because only one codon is permitted at each position in a reading frame.
The polypeptides will be identical because the ribosome ignores codon differences unless a stop codon is present.
Explanation
This question analyzes how codon differences affect polypeptide sequences during translation. When position 5 contains different codons in the two mRNAs, different tRNAs will bind at that position, each delivering its specific amino acid (M for mRNA X, N for mRNA Y), resulting in polypeptides that differ by exactly one amino acid at position 5. All other positions remain identical because the codon sequences are the same, recruiting the same tRNAs and amino acids. Students choosing B incorrectly think ribosomes ignore codon differences, but the genetic code strictly determines which tRNA binds each codon. To predict polypeptide differences, compare codon sequences position by position and use the genetic code to determine amino acid changes.
In an in vitro translation reaction, tRNAs are charged with amino acids by aminoacyl-tRNA synthetases before entering the ribosome. A mutation reduces the ability of one synthetase to attach its amino acid to its specific tRNA, but the tRNA can still base-pair normally with its matching codon in the ribosome. Ribosomes, mRNA, and all other charged tRNAs are abundant. Which outcome is most likely for polypeptides produced from mRNAs containing that codon?
Polypeptides will frequently stall at that codon because uncharged matching tRNA cannot donate an amino acid.
Polypeptides will be unchanged because amino acids bind directly to codons without requiring tRNAs.
Ribosomes will incorporate a different amino acid at that codon because codon-anticodon pairing changes.
Transcription will fail for those mRNAs because synthetases are required to synthesize RNA nucleotides.
Translation will terminate at that codon because the codon becomes a stop codon when tRNA is uncharged.
Explanation
This question tests understanding of how uncharged tRNAs affect translation elongation. When a specific aminoacyl-tRNA synthetase cannot charge its tRNA with the appropriate amino acid, that tRNA enters the ribosome without an amino acid attached. While the uncharged tRNA can still base-pair with its codon in the A site, it cannot donate an amino acid for peptide bond formation, causing the ribosome to stall at that position. Students choosing A incorrectly think a different amino acid would be incorporated, but synthetases are highly specific and other synthetases won't charge this tRNA. To analyze translation efficiency problems, consider whether all components (charged tRNAs, release factors, elongation factors) are functional at each step.
A researcher engineers an mRNA with a strong secondary structure (a stable hairpin) that forms within the coding region. The hairpin begins just after codon 6 and physically impedes ribosome movement along the mRNA, but it does not change the codon sequence itself. Initiation occurs normally at the start codon, and tRNAs are available. Which outcome is most likely for translation of this mRNA?
Termination will occur at codon 6 because a hairpin is recognized as a stop codon by release factors.
Elongation will slow or pause near codon 6 because ribosome translocation is hindered.
The amino acid sequence will be unchanged and synthesized at the same rate because hairpins affect only DNA replication.
Ribosomes will transcribe a complementary RNA strand to unwind the hairpin and continue translation.
Translation will start at codon 6 because hairpins convert upstream codons into introns that are spliced out.
Explanation
This question tests understanding of how mRNA secondary structures affect ribosome movement. A stable hairpin structure in the mRNA creates a physical barrier that impedes the ribosome's translocation along the mRNA during elongation, causing translation to slow or pause when the ribosome encounters this structure around codon 6. The ribosome can eventually unfold the hairpin through its helicase activity, but this takes time and energy, reducing translation speed. Students choosing C incorrectly think RNA structures don't affect translation, confusing this with DNA replication, but ribosomes must physically move along mRNA and can be blocked by stable structures. To analyze translation efficiency, consider both the sequence information and physical accessibility of the mRNA.
In a bacterial cell, translation can begin on an mRNA while the mRNA is still being synthesized. A mutation changes the start codon AUG to AUC in an mRNA, but the rest of the coding region remains unchanged and contains no other start codons nearby. Assume the ribosome requires AUG to initiate efficiently at that site. Which outcome is most likely for translation of the mutated mRNA?
Termination will occur at the first codon because AUC is recognized by release factors as a stop signal.
The mRNA will be converted into DNA before translation, restoring AUG at the start position.
Translation initiation will be greatly reduced because the initiator tRNA does not recognize the altered codon.
Elongation will proceed but will skip the first amino acid because the ribosome begins at codon 2 automatically.
Translation will initiate normally because any codon can serve as a start codon if tRNAs are abundant.
Explanation
This question tests understanding of translation initiation requirements. The initiator tRNA specifically recognizes the AUG start codon through complementary base pairing, and changing AUG to AUC prevents this recognition, greatly reducing or eliminating translation initiation at that site. Without proper initiation complex formation at the intended start site, the ribosome cannot begin elongation from the correct position. Students choosing A incorrectly think any codon can serve as a start codon, but prokaryotic and eukaryotic ribosomes specifically require AUG (occasionally GUG or UUG in bacteria) for efficient initiation. When analyzing translation efficiency, remember that initiation is a highly regulated step requiring specific sequences and factors.